期刊文献+

老年透析患者隧道式中心静脉置管相关血流感染临床分析 被引量:9

An analysis of catheter-related bloodstream infections in old hemodialysis patients with tunneled central venous catheterization
下载PDF
导出
摘要 目的探讨老年血液透析患者隧道式中心静脉置管所致导管相关血流感染(catheter-related bloodstream infections,CRBSI)的病原菌及相关因素。方法选择北京同仁医院使用隧道式中心静脉置管的老年维持性血液透析患者26例,根据血培养结果分为感染组和非感染组,分析CRBSI患者血培养分离出的病原菌及相关因素。结果老年血液透析患者隧道式中心静脉置管CRBSI的发生率为1.36次/1000导管日。CRBSI患者血培养阳性8例,分离出病原菌9株,包括表皮葡萄球菌3株(33.3%)、金黄色葡萄球菌2株(22.2%)、人葡萄球菌1株(11.1%)、超广谱β内酰胺酶阳性大肠埃希菌1株(11.1%)、绿脓杆菌1株(11.1%)、肺炎克雷伯杆菌1株(11.1%)。导管留置时间是CRBSI的独立危险因素(OR值为11.09,P<0.05)。低白蛋白水平与CRBSI的发生相关。CRBSI患者降钙素原水平明显升高。结论使用隧道式中心静脉置管的老年血液透析患者随留置导管时间的增加易发生CRBSI,应引起临床医生的重视。 Objective To study catheter-related bloodstream infections (CRBSI) in old hemodialysis patients with tunneled central venous catheterization. Methods Twenty-six old hemodialysis patients with tunneled central venous catheterization were observed and analyzed. Results The incidence of CRBSI in old hemodialysis patients with tunneled central venous catheterization was 1.36 times/1000 catheterization days. Nine strains bacteria were isolated. The bacteria included Staphylococcus epidermidis(33.3%), Staphylococcus aureus (22.2%), Staphylococcus hominis (11.1%), extended spectrum beta-lactamases type Escherichia coil (11.1%), pseudomonas aeruginosa (11.1%), Klebsiella pneumoniae procalcitonin of patients with CRBSI were remarkablely increased. Catheter indwelling time was an independent risk factor for CRBSI (OR = 11.09, P 〈 0.05). LoW albumin level was associated with CRBSI. The level of procalcitonin of patients with CRBSI was increased obviously. Conclusion Prolonged catheter indwelling time is an independent risk factor of CRBSI in old hemodialysis patients with tunneled central venous catheterization.
出处 《北京医学》 CAS 2012年第4期295-298,共4页 Beijing Medical Journal
关键词 导管相关血流感染 血液透析 Catheter-related bloodstream infection (CRBSI) Hemodialysis
  • 相关文献

参考文献16

  • 1Hoen B,Paul-Dauphin A,Hestin D. EPIBACDIAL:a multicenter prospective study of risk factors for bacteremia in chronic hemodialysis patients[J].Journal of the American Society of Nephrology,1998.869-876.
  • 2National Kidney Foundation. KDOQI clinical practice guidelines for vascular access[J].American Journal of Kidney Diseases,2006,(suppl 1):s248-s273.
  • 3北京市血液透析质量控制和改进中心.北京市血液透析登记2011年年度报告[J]中国血液净化,2011(suppl):6-8.
  • 4Pisoni RL,Young EW,Dykstra DM. Vascular access use in Europe and the United States:results from the DOPPS[J].Kidney International,2002.305-316.
  • 5Betjes MG,van Agteren M. Prevention of dialysis catheter-related sepsis with a citrate-taurolidine-containing lock solution[J].Nephrology Dialysis Transplantation,2004.1546-1551.
  • 6Oliver M.J,Callery SM,Thorpe KE. Risk of bacteremia from temporary hemodialysis catheters by site of insertion and duration of use:a prospective study[J].Kidney International,2000.2543-2545.
  • 7Yasmin J,Nicholas MS,Maarten W. A meta-analysis of hemodialysis catheter locking solution in the prevention of catheter-related infection[J].American Journal of Kidney Diseases,2008.233-241.
  • 8Sampathkumar K,Ramakrishnan M,Sah AK. Tunneled central venous catheters:experience from a single center[J].Indian J Nephrol,2011.107-111.
  • 9Lafrance JP,Rahme E,Lelorier J. Vascular access-related infection:definitions,incidence rates,and risk factors[J].American Journal of Kidney Diseases,2008.982-993.
  • 10Jean G,Chara B,Chazot C. Risk factor analysis for long-term tunneled dialysis catheter-related bacteremias[J].Nephron,2002.399-405.

二级参考文献12

  • 1Powe NR, Jaar B, Furth SL, et al. Septicemia in dialysis patients: incidence, risk factors, and prognosis[J]. Kidney Int, 1999,55: 1081-1090.
  • 2Marr K, Krekland, Seefon D, et al. Catheter related bacteremia in hemodialysis patients[J]. Ann Intern Med, 1997.
  • 3Sarnak MJ, Jaber BL. Mortality caused by sepsis in patients with end-stage renal disease compared with the general population[J]. Kidney Int, 2000,58: 1758-1764.
  • 4Grady NP, Alexander M, Dellinger EP, et al. Guidelines for the prevention of intravascular catheter-related infections. Centers for Disease Control and Prevention [J]. MMWR Recomm Rep, 2002, 51:1-29.
  • 5Shortell SM, Bennett CL, Byck GR. Assessing the impact of continuous quality improvement on clinical practice: what it will take to accelerate progress[J]. Milbank Q, 1998, 76:593-624, 510.
  • 6Mermel LA, Farr BM. Guidelines for the Prevention of Intravascular Catheter -Related Infections[J].Clinical Infectious Disease, 2001,22:222-242.
  • 7Burr R, Marszalek J, Saul M. The cost of vascular access infections: three years experience from a single outpatient dialysis center[J]. Hemodial Int, 2003,7:73-104.
  • 8Oliver MJ, Callery SM, Thorpe KE. Risk of bacteraemia from temporary haemodialysis catheters by site of insertion and duration of use: A prospective study[J]. Kidney Int, 2000,58: 2543-2545.
  • 9Saad TF. Bacteraemia associated with tunnelled, cuffed haemodialysis catheters[J]. Am.J. Kidney Dis, 1999,34: 1114- 1124.
  • 10Eggimann P, Pittet D. Overview of catheter - related infections with special emphasis on prevention based on educational p rograms[J]. Clin Microbiol Infect, 2002, 8: 295-309.

共引文献127

同被引文献81

引证文献9

二级引证文献56

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部